BioSpace News Archive

Drug Development

ProMIS Neurosciences to Present Preclinical Data on Alzheimer’s Disease Therapeutic Antibody PMN310 at Alzheimer’s Association International Conference

PMN310 Shows Potential for Best in Class Amyloid-Beta Oligomer Selectivity

July 10, 2018
·
4 min read
Business

PROVECTUS BIOPHARMACEUTICALS CLINICAL TRIALS UPDATE PROVIDED AT EUROPEAN POST-CHICAGO MELANOMA/SKIN CANCER MEETING

Provectus announced that a clinical trials update was provided at the 8th European Post-Chicago Melanoma/Skin Cancer Meeting, held in Munich, Germany from June 28-29.

July 10, 2018
·
3 min read
Business

Roivant Sciences Provides Corporate Updates in Advance of First Annual Pipeline Day

Myrtle Potter, former President and COO of Genentech, appointed Vant Operating Chair

July 10, 2018
·
4 min read
Drug Development

Tetra Discovery Partners Initiates Phase 2 Trial of BPN14770 in Fragile X Syndrome

Tetra Discovery Partners today announced the initiation of a Phase 2 study of BPN14770 as a potential treatment for Fragile X Syndrome

July 10, 2018
·
4 min read
Policy

Advaxis Provides Update on MAA Filing and ADXS-HOT Program

Advaxis, Inc. announced a clinical update

July 10, 2018
·
7 min read
Policy

European Medicines Agency Agrees with Pharnext’s Pediatric Investigation Plan for PXT3003

This agreement paves the way for the submission of a marketing authorization application in Europe

July 10, 2018
·
3 min read
CS Genetics Unveils New Modality for Noninvasive Molecular Diagnosis

CS Genetics has made a sequence of scientific, conceptual, and analytic advances regarding circulating nucleic acids which yield a powerful new modality for the noninvasive diagnosis of cancer and other major medical conditions.

July 10, 2018
·
3 min read
Business

PathoQuest Announces New Appointments to Executive Leadership Team

Company adds experienced executives to support the continued growth of Biologics Genomic Service and Clinical Diagnostics businesses which utilize PathoQuest’s proprietary Next-Generation Sequencing (NGS) based testing solution.

July 10, 2018
·
5 min read
Medicrea International Raises €3.1 Million

MEDICREA INTERNATIONAL announces a capital increase of €3,083,777 with 4 U.S. institutional investors.

July 10, 2018
·
10 min read
BioMidwest

cultivate(MD) Announces Investment Into SafKan Health

Genesis Innovation Group’s cultivate(MD) Capital Fund II, LP, a fund focused on investments in early stage healthcare companies with innovative technologies, announces its investment into SafKan Health, Inc.

July 10, 2018
·
3 min read